Nutritional efficacy and safety of APUXAN® demonstrated in clinical prevention trial
Oct 5, 2015, 2:30 PM
In a double-blind, randomised, placebo-controlled prevention trial, the efficacy of APUXAN2® was investigated for the prevention of common colds. It was demonstrated for APUXAN2® for the first time that there is a significantly higher ratio of cytotoxic and regu­latory T-cells in the APUXAN2® group for all cold episodes compared with the placebo group.
weiter lesen